The "Cutaneous Lupus Erythematosus Clinical Trial" at Sun Research Institute aims to evaluate innovative treatments for Cutaneous Lupus Erythematosus (CLE), a skin condition caused by systemic lupus erythematosus. This trial investigates the safety, efficacy, and potential side effects of new therapies designed to alleviate skin lesions, inflammation, and discomfort associated with CLE. By enrolling participants with active or chronic CLE, the study seeks to advance medical knowledge and improve treatment options for those affected by this challenging autoimmune disorder. The research is cond